NCT07389005
Exercise, Chronotype, and Prediabetes
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 25 words
- Start date changed from estimate of Sep 2026 to Oct 14, 2026
- Secondary endpoints: details revised at 9 of 12 entries
- Publications: details revised at 3 of 3 entries
- Notable Recruitment opened
- Start date: Feb 2026 to Sep 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Insulin sensitivity
Timeframe: 12 to 24 hours post-exercise intervention
Secondary (12)
Skeletal muscle metabolites
Skeletal muscle clock genes
Adipose tissue metabolites
Adipose tissue clock genes
Hepatic glycogen content assessed using 13C Magnetic Resonance Spectroscopy
Show 7 moreShow less
Serum glucose
Serum free fatty acids
Serum triglycerides
Serum cholesterol
Serum insulin
Resting energy expenditure assessed using indirect calorimetry
Objective sleep quantity and quality assessed using an actighrapy device
Arms and interventions
AM exerciseExperimental
Behavioral: Timing of exercise
PM exerciseExperimental
Behavioral: Timing of exercise
ControlActive comparator
Behavioral: Control
Behavioral: Timing of exercise, Control
Sites
1 site in 1 country
- German Diabetes Center (DDZ)Düsseldorf, Germany